|
Join us for a presentation by Dr. Lawrence Fong, one of the nation's leading experts in cancer immunotherapy and CAR-T cell therapies. Dr. Fong is the inaugural Bezos Distinguished Scholar and director of the Immunotherapy Integrated Research Center at Fred Hutchinson Cancer Center in Seattle.
Throughout his career, he has helped advance groundbreaking immunotherapy research, including clinical studies of anti-CTLA-4 and anti-PD-1 therapies that have become FDA-approved treatments for patients with cancer.
During this session Dr. Fong will explore how these rapidly evolving treatments are transforming cancer care, discuss emerging research and explain what the future of immunotherapy may mean for patients and providers.
|